Who is sponsoring NCT04538131?

NCT04538131 is sponsored by Ruijin Hospital.

What drugs are being tested in NCT04538131?

Interventions in NCT04538131: sensor-driven position-adaptive SCS, conventional SCS.

What condition does NCT04538131 study?

NCT04538131 studies Gait Disorders, Neurologic, Parkinson Disease.

Is NCT04538131 still recruiting?

NCT04538131 is currently status unknown. Last updated 3 September 2020.

Last reviewed 2020-09-03 · How we verify

NCT04538131

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adaptive SCS for Treatment of Gait Disturbance in PD

Status unknown NA Last updated 3 September 2020

What this trial tests

NA trial testing sensor-driven position-adaptive SCS in Gait Disorders, Neurologic in 8 participants. Status unknown.

Timeline

1 July 2020

Primary endpoint
30 September 2020

31 December 2020

Quick facts

Lead sponsor	Ruijin Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	8
Start date	1 July 2020
Primary completion	30 September 2020
Estimated completion	31 December 2020
Sites	1 location across China

Drugs / interventions tested

sensor-driven position-adaptive SCS
conventional SCS

Conditions studied

Gait Disorders, Neurologic — all drugs for Gait Disorders, Neurologic →
Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

Ruijin Hospital

Who can join

Adults 55 to 70, any sex, with Gait Disorders, Neurologic or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Spinal cord stimulation (SCS) has been suggested by several research for treating PD gait disturbance. However, the side effects induced by body position change cannot fully addressed by conventional SCS. Medtronic sensor-driven position-adaptive SCS are capable to monitor the position change and change the parameters accordingly, so as to reduce the position change related side effects. Nevertheless, neither the efficacy nor safety of this technique in the treatment of gait disturbance in PD is ever investigated. Therefore, the investigators will conduct a randomized clinical trial to investigate the clinical efficacy and safety of sensor-driven position-adaptive SCS in the treatment of gait disturbance in PD. This study will contribute to find out the safety and efficacy of sensor-driven position-adaptive SCS in the treatment of PD gait disorder, improve patients' quality of life, and reduce the burden on family and society.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gait Disorders, Neurologic

Currently open trials in the same condition.

NCT07118228 — Ultrasonographic Assessment of Muscle Morphology, Function, and Clinical Findings in Spastic Cerebral Palsy · recruiting
NCT07358338 — Application of Device-based Training to Improve Postural Control in Older Adults With CCI · NA · active not recruiting
NCT06906276 — Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes · recruiting
NCT06593184 — Efficacy of Trans-spinal Magnetic Stimulation on Functional Mobility in Chronic Stroke Patients · NA · recruiting
NCT07073287 — Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients · Phase 2 · recruiting

Other Ruijin Hospital trials

Trials by the same sponsor.

NCT07589361 — Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors · not yet recruiting
NCT07449507 — Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy · NA · not yet recruiting
NCT07496385 — Clinical Study on the Efficacy of Subglottic Suction in Mechanically Ventilated Patients Guided by Bedside Ultrasound · NA · not yet recruiting
NCT07511114 — A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyp · Phase 3 · not yet recruiting
NCT07514169 — The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04538131 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ruijin Hospital
Last refreshed: 3 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04538131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing